Cabaletta Bio, Inc.·4

Oct 15, 4:39 PM ET

Gavel Steve 4

4 · Cabaletta Bio, Inc. · Filed Oct 15, 2025

Insider Transaction Report

Form 4
Period: 2025-10-13
Gavel Steve
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-10-13+275,000275,000 total
    Exercise: $2.49Exp: 2035-10-12Common Stock (275,000 underlying)
Footnotes (2)
  • [F1]The stock option has been granted pursuant to the Cabaletta Bio, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4).
  • [F2]25% of the shares underlying this option shall vest and become exercisable on October 13, 2026, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4